1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Dentium Co., Ltd.

Dentium Co., Ltd.

KKRX:145720
40,700.00
KRW
+1,200.00
(+3.04%)
3,479.13EPS
11.31P/E
342.37BMarket Cap
Nov 16Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
9,379.51
12,132.28
15,713.74
19,745.74
18,468.43
21,605.16
29,280.75
26,638.84
33,806.14
41,265.27
45,594.37
47,286.7
40,174.65
40,560.07
Basic EPS, GAAP
1,874
2,507
2,383
3,256
3,686
3,972
1,714
2,614
6,434
9,980
11,193
8,431
1,903
3,510.08
Free Cash Flow per Basic Share
1,028.09
-1,825.95
-2,175.65
-229.32
-6,298.52
-12,686.96
-7,428.52
7,729.59
5,226.27
-823.27
2,416.88
1,716.95
-4,675.13
-2,033.31
Dividend per Share
49.87
58.09
70.01
99.99
74.51
150
149.96
- -
200.01
250
300.01
399.99
600.02
- -
Book Value per Share
7,723.46
6,715.22
7,983.66
11,353.53
18,767.9
22,506.11
23,995.56
26,588.26
33,840.87
43,354.09
53,873.92
64,317.38
65,217.87
69,121.28
Tangible Book Value per Share
7,219.02
6,284.79
7,512.85
10,987.35
18,556.8
22,227.9
23,726.38
26,340.63
33,583.56
43,025.83
53,414.27
63,601.44
64,630.35
68,564.19
Basic Weighted Avg Shares
8
7
6
6
8
9
9
9
9
9
9
9
9
9
Sales/Revenue/Turnover
73,922
82,396
95,489
120,034
150,646
186,316
252,587
229,749
291,530
355,866
393,189
407,807
346,452
348,094
Operating Margin (%)
27.98
21.98
17.57
23.77
27.27
22.53
17.69
17.24
24.07
35.33
35.17
24.15
18.5
19.97
Depreciation Expense
2,136
2,600
3,527
3,956
4,893
4,989
13,375
14,790
13,206
18,949
20,884
23,206
25,192
27,030
Net Income, GAAP
14,769
17,026
14,481
19,793
30,066
34,253
14,786
22,545
55,484
86,066
96,524
72,710
16,411
30,124
Effective Tax Rate (%)
26.22
11.88
16.81
24.2
15.58
18.45
59.2
14.72
25.72
27.24
28.22
22.91
29.37
45.78
Profit Margin (%)
19.98
20.66
15.17
16.49
19.96
18.38
5.85
9.81
19.03
24.18
24.55
17.83
4.74
8.65
Working Capital
19,482
3,061
-7,336
-4,041
52,050
29,511
51,062
1,986
60,056
74,428
107,620
183,234
138,326
147,977
LT Debt
4,598
9,899
22,050
19,933
49,661
99,330
160,890
83,979
95,973
70,295
45,122
45,197
48,714
56,889
Total Equity
43,836
41,027
48,763
69,440
162,465
194,734
206,533
228,601
291,098
373,164
463,873
553,506
561,206
594,634
Return on Invested Capital (%)
24.03
20.35
13.72
16.85
16.81
10.53
4.29
7.58
11.77
18.18
16.42
10.28
5.43
4.46
Return on Capital (%)
23.13
21.46
14.36
15.28
14.83
10.92
4.15
6.42
12.88
17.06
16.24
10.84
2.9
4.26
Return on Common Equity (%)
37.09
38.8
32.42
33.68
26.05
19.25
7.37
10.34
21.29
25.86
23.02
14.27
2.94
5.27

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
239,323
249,893
243,549
LT Borrowings
46,757
57,641
52,167
LT Finance Leases
1,957
3,583
4,722
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
398,424
441,543
342,368

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
456,115
493,562
477,655
Cash, Cash Equivalents & STI
88,604
101,353
75,934
Accounts Receivable, Net
142,162
141,211
147,090
Inventories
204,449
227,928
233,015
Total Current Liabilities
317,788
329,739
329,678
Payables & Accruals
- -
- -
- -
ST Debt
239,323
249,893
243,549
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
31.35%
20.11%
1.39%
Free Cash Flow
242.06%
-188.59%
-372.28%
Net Income, GAAP
20.94%
22.26%
-77.43%
Sales/Revenue/Turnover
14.95%
9.62%
-15.05%
Total Cash Common Dividend
- -
- -
50%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
82,733
111,672
94,677
118,725
407,807
2025
76,834
82,253
78,219
109,146
346,452
2026
71,383
89,346
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,938
2,393
4,091
2,402.31
8,431
2025
1,463
554
463.27
-577.44
1,903
2026
1,994.05
1,645.06
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
399.99
2025
- -
- -
- -
- -
600.02
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
Full Time Employees
876
Sector
Health technology
Industry
Medical specialties
Address
21, Teheran-ro 87-gil Suwon-si GY South Korea
IPO Date
Mar 15, 2017
Website
dentium.co.kr
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Dentium Co., Ltd. (145720.KS) manufactures and sells dental implants, instruments, and related medical devices worldwide; its core implant systems include SuperLine, Implantium, Implantium 2, N.R. line, Simple Line 2, and Slim line, complemented by regeneration products such as synthetic bones and collagen membranes; digital dentistry solutions encompassing rainbow CAD/CAM systems, CT scanners, mills, and lab components like zirconia blocks and porcelain; orthodontics, bright resin, tooth care products, and surgical kits. The company, founded in 2000 and headquartered in Seoul, South Korea, previously known as Biostech Co., Ltd. until its name change in August 2002, operates primarily in the medical instruments and supplies sector with approximately 800-835 employees, serving clinicians globally through a value-segment strategy emphasizing high-quality, cost-effective solutions and vertical integration from research and development to sales. Dentium maintains significant manufacturing presence in Asia, including subsidiaries like ICT Vina in Vietnam's Danang Hi-Tech Park, where it has progressively invested--$20 million in ICT Vina (2018), $60 million in ICT Vina II (2020), and $177 million in ICT Vina III (approved late 2024, with land allocated early 2025 for production of artificial teeth and fuel cells, elevating total commitment to $257 million); in 2025, Align Partners acquired a 7.17% equity stake through open-market purchases, boosting shares over 15%, while Q3 2025 results showed regeneration sales up 8% year-over-year amid overseas implant growth in Asia (particularly Vietnam) and Europe (Russia up 103%).